Sanofi (NASDAQ: SNY) reported Q3 EPS of EUR2.30, EUR0.72 better than the analyst estimate of EUR1.58. Revenue for the quarter came in at EUR12.43 billion versus the consensus estimate of EUR15 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.